James A. Geraghty, Director at IDERA PHARMACEUTICALS, INC. (IDRA), bought 40,000 shares at $2.72 ($109K) on 2013-12-06, disclosed to the SEC on 2013-12-09.
Open-market purchase of $109k IDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |